🇺🇸 FDA
Patent

US 7265086

Glycopeptide carboxy-saccharide derivatives

granted A61KA61K38/00A61K47/40

Quick answer

US patent 7265086 (Glycopeptide carboxy-saccharide derivatives) held by Theravance, Inc. expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61K47/40, A61K47/6951, A61K9/0014